CCL5 as an adjuvant for cancer immunotherapy (Q37710085)

22 August 2017

1 reference

title

CCL5 as an adjuvant for cancer immunotherapy (English)

1 reference

22 August 2017

1 reference

1 reference

Natalia Lapteva

1

1 reference

PubMed ID

20233026

22 August 2017

Xue F Huang

series ordinal

2

1 reference

PubMed ID

20233026

22 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Expert Opinion on Biological Therapy

22 August 2017

1 reference

22 August 2017

10

1 reference

22 August 2017

5

1 reference

22 August 2017

725-733

1 reference

RANTES chemokine expression in diseased and normal human tissues

22 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Distinct patterns and kinetics of chemokine production regulate dendritic cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Interleukin (IL)-10 inhibits RANTES-, tumour necrosis factor (TNF)- and nerve growth factor (NGF)-induced mast cell migratory response but is not a mast cell chemoattractant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Chemokines as regulators of T cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Tissue cytokine and chemokine expression in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

RANTES is a pro-inflammatory chemokine and chemoattracts basophil cells to extravascular sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Serial analysis of gene expression in progressing and regressing mouse tumors implicates the involvement of RANTES and TARC in antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Expression of CCL5 (RANTES) and CCR5 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

CCR5 expression influences the progression of human breast cancer in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Tumor-derived CCL5 does not contribute to breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

The inflammatory chemokines CCL2 and CCL5 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Inflammation, microenvironment, and the immune system in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712591003657128

10.1517/14712591003657128

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20233026